Short, plain-language guides on GLP-1 therapy and metabolic health, written and reviewed by ZIVOLABS doctors. No clickbait. No miracle promises.
Browse the full article libraryThese are complex biologic medicines with cold-chain logistics and high global demand. Prices should ease as more brands and, eventually, generics enter the market.
Usually only when prescribed for diabetes, not for weight loss alone, which most policies treat as a lifestyle condition. Check your policy and use any medical-reimbursement allowance.
Typically ₹14,000–₹28,000 a month depending on dose. As a newer dual-action medicine it sits at the higher end; confirm current pricing with a licensed pharmacy.
Roughly ₹7,000–₹15,000 a month depending on dose and pharmacy. Prices move, and grey-market 'deals' far below this are a red flag for counterfeits.
Use the lowest effective dose, pick the right molecule for your goal, buy a full month at a time, and use any medical reimbursement — all through licensed channels.
Medical expenses for specified conditions may be claimable under sections like 80DDB in certain cases. Keep invoices and prescriptions and check with a tax advisor.
Some doctor-supervised programs offer monthly plans that spread the cost and bundle the consult and delivery. Compare the all-in cost, not just the pen price.
Yes — under the 2020 Telemedicine Practice Guidelines, a valid teleconsult prescription with the doctor's registration and e-signature is legally equivalent to an in-person one.
Practically, pharmacies often expect a prescription within the last six months, with the doctor's registration number. A supervised program keeps yours current automatically.
Personal import rules are restrictive and risky — customs issues, broken cold chain and no recourse if it's fake. Buying from a licensed Indian pharmacy is safer and simpler.
Licensed online pharmacies can dispense GLP-1 against a valid prescription. The key is a real prescription and genuine cold-chain handling — not a seller shipping without one.
Indian generic and biosimilar semaglutide is expected as key patents lapse, which should lower prices. Until then, stick to approved branded products from licensed pharmacies.
